Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
Loading...

Hypera S.A.

HYPMYPNK
Healthcare
Drug Manufacturers - Specialty & Generic
$4.43
$-0.08(-1.77%)
U.S. Market is Open • 14:46

Hypera S.A. Fundamental Analysis

Hypera S.A. (HYPMY) shows moderate financial fundamentals with a PE ratio of 12.59, profit margin of 15.53%, and ROE of 9.86%. The company generates $8.4B in annual revenue with moderate year-over-year growth of 3.45%.

Key Strengths

Operating Margin22.59%
Cash Position57.06%
PEG Ratio0.05

Areas of Concern

ROE9.86%
We analyze HYPMY's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 48.8/100 based on profitability, valuation, growth, and balance sheet metrics. The D grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

D
48.8/100

We analyze HYPMY's fundamental strength across five key dimensions:

Efficiency Score

Weak

HYPMY struggles to generate sufficient returns from assets.

ROA > 10%
4.75%

Valuation Score

Excellent

HYPMY trades at attractive valuation levels.

PE < 25
12.59
PEG Ratio < 2
0.05

Growth Score

Weak

HYPMY faces weak or negative growth trends.

Revenue Growth > 5%
3.45%
EPS Growth > 10%
-11.79%

Financial Health Score

Excellent

HYPMY maintains a strong and stable balance sheet.

Debt/Equity < 1
0.75
Current Ratio > 1
1.47

Profitability Score

Moderate

HYPMY maintains healthy but balanced margins.

ROE > 15%
9.86%
Net Margin ≥ 15%
15.53%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is HYPMY Expensive or Cheap?

P/E Ratio

HYPMY trades at 12.59 times earnings. This suggests potential undervaluation.

12.59

PEG Ratio

When adjusting for growth, HYPMY's PEG of 0.05 indicates potential undervaluation.

0.05

Price to Book

The market values Hypera S.A. at 1.20 times its book value. This may indicate undervaluation.

1.20

EV/EBITDA

Enterprise value stands at 3.88 times EBITDA. This is generally considered low.

3.88

How Well Does HYPMY Make Money?

Net Profit Margin

For every $100 in sales, Hypera S.A. keeps $15.53 as profit after all expenses.

15.53%

Operating Margin

Core operations generate 22.59 in profit for every $100 in revenue, before interest and taxes.

22.59%

ROE

Management delivers $9.86 in profit for every $100 of shareholder equity.

9.86%

ROA

Hypera S.A. generates $4.75 in profit for every $100 in assets, demonstrating efficient asset deployment.

4.75%

Following the Money - Real Cash Generation

Operating Cash Flow

Hypera S.A. generates strong operating cash flow of $2.63B, reflecting robust business health.

$2.63B

Free Cash Flow

Hypera S.A. generates strong free cash flow of $1.83B, providing ample flexibility for dividends, buybacks, or growth.

$1.83B

FCF Per Share

Each share generates $2.61 in free cash annually.

$2.61

FCF Yield

HYPMY converts 10.14% of its market value into free cash.

10.14%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

12.59

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

0.05

vs 25 benchmark

P/B Ratio

Price to book value ratio

1.20

vs 25 benchmark

P/S Ratio

Price to sales ratio

2.14

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.75

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.47

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.10

vs 25 benchmark

ROA

Return on assets percentage

0.05

vs 25 benchmark

ROCE

Return on capital employed

0.08

vs 25 benchmark

How HYPMY Stacks Against Its Sector Peers

MetricHYPMY ValueSector AveragePerformance
P/E Ratio12.5928.50 Better (Cheaper)
ROE9.86%836.00% Weak
Net Margin15.53%-22564.00% (disorted) Strong
Debt/Equity0.750.30 Weak (High Leverage)
Current Ratio1.474.53 Neutral
ROA4.75%-14951.00% (disorted) Weak

HYPMY outperforms its industry in 2 out of 6 key metrics, particularly excelling in Net Margin, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Hypera S.A.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

86.02%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

-8.82%

Industry Style: Defensive, Growth, Innovation

Declining

FCF CAGR

19.27%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ